Years after ALLHAT, alpha-blocker use common, risky. IN Your dose of medicine [column]

Years after ALLHAT, alpha-blocker use common, risky. IN Your dose of medicine [column]

Detalles Bibliográficos
Publicado en:Philippine Star Vol. 34, no. 183 (26 Jan. 2020), 9
Autor Principal: Chante, Charles C.
Formato: Artigo
Publicado: 2020
Subjects:
Heart diseases
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Heart failure